Literaturverzeichnis

Literaturverzeichnis

[1] Cervera, R. und Shoenfeld, Y. (2007): Pathogenic mechanisms and clinical relevance of autoantibodies, Shoenfeld, Y.; Gershwin, M. E. und Meroni, P. L., Autoantibodies , 2. Auflage, Seite 29-35, Elsevier Academic Press, London, ISBN: 978-0-444-52763-9.

[2] Oertelt, S.; Invernizzi, P.; Podda, M. und Gershwin, M. E. (2007): What is an autoantibody?, Shoenfeld, Y.; Gershwin, M. E. und Meroni, P. L., Autoantibodies , 2. Auflage, Seite 3-6, Elsevier Academic Press, London, ISBN: 978-0-444-52763-9.

[3] Amital, H. und Shoenfeld, Y. (2007): Natural autoantibodies, heralding, protecting and inducing autoimmunity, Shoenfeld, Y.; Gershwin, M. E. und Meroni, P. L., Autoantibodies , 2. Auflage, Seite 7-12, Elsevier Academic Press, London, ISBN: 978-0-444-52763-9.

[4] Avrameas, S. und Ternynck, T. (1993): The natural autoantibodies system: between hypotheses and facts, Mol.Immunol. (Band 30), Nr. 12, Seite 1133-1142. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8366863

[5] Kohler, H.; Bayry, J.; Nicoletti, A. und Kaveri, S. V. (2003): Natural autoantibodies as tools to predict the outcome of immune response?, Scand.J.Immunol. (Band 58), Nr. 3, Seite 285-289. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12950673

[6] Cohen, I. R. (2000): Discrimination and dialogue in the immune system, Semin.Immunol. (Band 12), Nr. 3, Seite 215-219. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10910742

[7] Gorsuch, A. N.; Spencer, K. M.; Lister, J.; McNally, J. M.; Dean, B. M.; Bottazzo, G. F. und Cudworth, A. G. (1981): Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus, Lancet (Band 2), Nr. 8260-61, Seite 1363-1365. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=6118756

[8] Harel, M. und Shoenfeld, Y. (2006): Predicting and preventing autoimmunity, myth or reality?, Ann.N.Y.Acad.Sci. (Band 1069), Seite 322-345. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16855160

[9] Arbuckle, M. R.; McClain, M. T.; Rubertone, M. V.; Scofield, R. H.; Dennis, G. J.; James, J. A. und Harley, J. B. (2003): Development of autoantibodies before the clinical onset of systemic lupus erythematosus, N.Engl.J.Med. (Band 349), Nr. 16, Seite 1526-1533. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14561795

[10] Dechend, R.; Gratze, P.; Wallukat, G.; Shagdarsuren, E.; Plehm, R.; Bräsen, J. H.; Fiebeler, A.; Schneider, W.; Caluwaerts, S.; Vercruysse, L.; Pijnenborg, R.; Luft, F. C. und Müller, D. N. (2005): Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsia, Hypertension (Band 45), Nr. 4, Seite 742-746. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15699466

[11] Dechend, R.; Homuth, V.; Wallukat, G.; Kreuzer, J.; Park, J. K.; Theuer, J.; Juepner, A.; Gulba, D. C.; Mackman, N.; Haller, H. und Luft, F. C. (2000): AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor, Circulation (Band 101), Nr. 20, Seite 2382-2387. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10821814

[12] Wallukat, G.; Morwinski, M.; Kowal, K.; Förster, A.; Boewer, V. und Wollenberger, A. (1991): Autoantibodies against the beta-adrenergic receptor in human myocarditis and dilated cardiomyopathy: beta-adrenergic agonism without desensitization, Eur.Heart J. (Band 12 Suppl D), Seite 178-181. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1717272

[13] Wallukat, G. und Wollenberger, A. (1991): Autoantibodies to beta 2-adrenergic receptors with antiadrenergic activity from patients with allergic asthma, J.Allergy Clin.Immunol. (Band 88), Nr. 4, Seite 581-587. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1655856

[14] Fu, M. L.; Herlitz, H.; Wallukat, G.; Hilme, E.; Hedner, T.; Hoebeke, J. und Hjalmarson, A. (1994): Functional autoimmune epitope on alpha 1-adrenergic receptors in patients with malignant hypertension, Lancet (Band 344), Nr. 8938, Seite 1660-1663. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7527885

[15] Dörffel, W. V.; Felix, S. B.; Wallukat, G.; Brehme, S.; Bestvater, K.; Hofmann, T.; Kleber, F. X.; Baumann, G. und Reinke, P. (1997): Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy, Circulation (Band 95), Nr. 8, Seite 1994-1997. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9133505

[16] Felix, S. B.; Staudt, A.; Dörffel, W. V.; Stangl, V.; Merkel, K.; Pohl, M.; Docke, W. D.; Morgera, S.; Neumayer, H. H.; Wernecke, K. D.; Wallukat, G.; Stangl, K. und Baumann, G. (2000): Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study, J.Am.Coll.Cardiol. (Band 35), Nr. 6, Seite 1590-1598. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10807465

[17] Müller, J.; Wallukat, G.; Dandel, M.; Bieda, H.; Brandes, K.; Spiegelsberger, S.; Nissen, E.; Kunze, R. und Hetzer, R. (2000): Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy, Circulation (Band 101), Nr. 4, Seite 385-391. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10653829

[18] Dragun, D.; Müller, D. N.; Bräsen, J. H.; Fritsche, L.; Nieminen-Kelhä, M.; Dechend, R.; Kintscher, U.; Rudolph, B.; Hoebeke, J.; Eckert, D.; Mazak, I.; Plehm, R.; Schönemann, C.; Unger, T.; Budde, K.; Neumayer, H. H.; Luft, F. C. und Wallukat, G. (2005): Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection, N.Engl.J.Med. (Band 352), Nr. 6, Seite 558-569.

[19] Wallukat, G.; Nissen, E.; Müller, J.; Brinckmann, R.; Schimke, I. und Kunze, R. (2002): The pathophysiological role of autoantibodies directed to G-protein coupled receptors and therapeutic strategies of antibody removal, Conrad, K.; Fritzler, M.; Meurer, M.; Sack, U. und Shoenfeld, Y., From proteomics to molecular epidemiology: Relevance of autoantibodies. Report on the 6th Symposium on Autoantibodies , Seite 332-372, Dresden.

[20] Luther, H. P.; Homuth, V. und Wallukat, G. (1997): Alpha 1-adrenergic receptor antibodies in patients with primary hypertension, Hypertension (Band 29), Nr. 2, Seite 678-682. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9040456

[21] Wallukat, G.; Nissen, E.; Morwinski, R. und Müller, J. (2000): Autoantibodies against the beta- and muscarinic receptors in cardiomyopathy, Herz. (Band 25), Nr. 3, Seite 261-266.

[22] Elies, R.; Ferrari, I.; Wallukat, G.; Lebesgue, D.; Chiale, P.; Elizari, M.; Rosenbaum, M.; Hoebeke, J. und Levin, M. J. (1996): Structural and functional analysis of the B cell epitopes recognized by anti-receptor autoantibodies in patients with Chagas' disease, J.Immunol. (Band 157), Nr. 9, Seite 4203-4211. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8892658

[23] Sterin-Borda, L.; Perez, Leiros C.; Wald, M.; Cremaschi, G. und Borda, E. (1988): Antibodies to beta 1 and beta 2 adrenoreceptors in Chagas' disease, Clin.Exp.Immunol. (Band 74), Nr. 3, Seite 349-354.

[24] Wallukat, G. und Wollenberger, A. (1987): Effects of the serum gamma globulin fraction of patients with allergic asthma and dilated cardiomyopathy on chronotropic beta adrenoceptor function in cultured neonatal rat heart myocytes, Biomed.Biochim.Acta. (Band 46), Nr. 8-9, Seite S634-S639.

[25] Wallukat, G.; Homuth, V.; Fischer, T.; Lindschau, C.; Horstkamp, B.; Jupner, A.; Baur, E.; Nissen, E.; Vetter, K.; Neichel, D.; Dudenhausen, J. W.; Haller, H. und Luft, F. C. (1999): Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor, J.Clin.Invest. (Band 103), Nr. 7, Seite 945-952.

[26] Fu, M. L.; Herlitz, H.; Schulze, W.; Wallukat, G.; Micke, P.; Eftekhari, P.; Sjogren, K. G.; Hjalmarson, A.; Muller-Esterl, W. und Hoebeke, J. (2000): Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension, J.Hypertens. (Band 18), Nr. 7, Seite 945-953. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10930193

[27] Dragun, D; Wallukat, G.; Dechend, R.; Bräsen, J. H.; Müller, D. N.; Neumayer, H. H.; Budde, K. und Luft, F. C. (2002): Agonistic antibodies targeting angiotensin II type 1 receptor cause acute vascular rejection in the absence of immunological risk, Conrad, K.; Fritzler, M.; Meurer, M.; Sack, U. und Shoenfeld, Y., From proteomics to molecular epidemiology: Relevance of autoantibodies. Report on the 6th Symposium on Autoantibodies , Seite 381-382, Dresden.

[28] Fu, L. X.; Magnusson, Y.; Bergh, C. H.; Liljeqvist, J. A.; Waagstein, F.; Hjalmarson, A. und Hoebeke, J. (1993): Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy, J.Clin.Invest (Band 91), Nr. 5, Seite 1964-1968. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7683693

[29] Eftekhari, P.; Salle, L.; Lezoualc'h, F.; Mialet, J.; Gastineau, M.; Briand, J. P.; Isenberg, D. A.; Fournie, G. J.; Argibay, J.; Fischmeister, R.; Muller, S. und Hoebeke, J. (2000): Anti-SSA/Ro52 autoantibodies blocking the cardiac 5-HT4 serotoninergic receptor could explain neonatal lupus congenital heart block, Eur.J.Immunol. (Band 30), Nr. 10, Seite 2782-2790. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11069058

[30] Lewis, R. A.; Selwa, J. F. und Lisak, R. P. (1995): Myasthenia gravis: immunological mechanisms and immunotherapy, Ann.Neurol. (Band 37 Suppl 1:S51-62.), Seite S51-S62.

[31] Costagliola, S.; Morgenthaler, N. G.; Hoermann, R.; Badenhoop, K.; Struck, J.; Freitag, D.; Poertl, S.; Weglohner, W.; Hollidt, J. M.; Quadbeck, B.; Dumont, J. E.; Schumm-Draeger, P. M.; Bergmann, A.; Mann, K.; Vassart, G. und Usadel, K. H. (1999): Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease, J.Clin.Endocrinol.Metab (Band 84), Nr. 1, Seite 90-97. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9920067

[32] (1990): Pschyrembel Klinisches Wörterbuch, 256., neu bearb. Auflage. Auflage , Walter de Gruyter & Co., Berlin, ISBN: 3-11-010881-X.

[33] Caspary, L. und Creutzig, A. (2006): [Raynaud's phenomenon--current diagnosis and therapy], Dtsch.Med.Wochenschr. (Band 131), Nr. 21, Seite 1223-1227. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16721713

[34] Doutre, M. (1999): Physiopathology of urticaria, Eur.J.Dermatol. (Band 9), Nr. 8, Seite 601-605.

[35] Furman, M. I.; Benoit, S. E.; Barnard, M. R.; Valeri, C. R.; Borbone, M. L.; Becker, R. C.; Hechtman, H. B. und Michelson, A. D. (1998): Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease, J.Am.Coll.Cardiol. (Band 31), Nr. 2, Seite 352-358.

[36] Golino, P.; Crea, F. und Willerson, J. T. (2002): How to study the effects of platelet aggregation and thrombosis on coronary vasomotion and their clinical relevance, Ital.Heart J. (Band 3), Nr. 4, Seite 220-225.

[37] Machado, A. P.; Saavedra, J. A. und Ribeiro, C. (1994): Insights into the role of thromboxane A2 and serotonin in the pathogenesis of unstable angina, Rev.Port.Cardiol. (Band 13), Nr. 12, Seite 935-46, 893.

[38] Herve, P.; Humbert, M.; Sitbon, O.; Parent, F.; Nunes, H.; Legal, C.; Garcia, G. und Simonneau, G. (2001): Pathobiology of pulmonary hypertension. The role of platelets and thrombosis, Clin.Chest Med. (Band 22), Nr. 3, Seite 451-458.

[39] Mosler, N (14-3-2007):Pulmonale Hypertonie - Neuer Wirkstoff für PAH-Therapie, Cardio News, Seite 16-16.

[40] Erdmann, E (14-3-2007):PAH-Patienten hilft, was Rauchern die Männlichkeit zurückgeben kann, Cardio News, Seite 14-14.

[41] Hoeper, M. (14-3-2007):Neue pharmakologische Therapien: Lässt sich die Transplantation bei Lungenhochdruck verhindern?, Cardio News, Seite 14-15.

[42] Altieri, D. C. und Edgington, T. S. (1990): Identification of effector cell protease receptor-1. A leukocyte-distributed receptor for the serine protease factor Xa, J.Immunol. (Band 145), Nr. 1, Seite 246-253. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2162887

[43] Behrendt, N.; Ronne, E. und Dano, K. (1995): The structure and function of the urokinase receptor, a membrane protein governing plasminogen activation on the cell surface, Biol.Chem.Hoppe Seyler (Band 376), Nr. 5, Seite 269-279. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7662169

[44] Dery, O.; Corvera, C. U.; Steinhoff, M. und Bunnett, N. W. (1998): Proteinase-activated receptors: novel mechanisms of signaling by serine proteases, Am.J.Physiol (Band 274), Nr. 6 Pt 1, Seite C1429-C1452. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9696685

[45] Vu, T. K.; Hung, D. T.; Wheaton, V. I. und Coughlin, S. R. (1991): Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation, Cell (Band 64), Nr. 6, Seite 1057-1068. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1672265

[46] Colognato, R.; Slupsky, J. R.; Jendrach, M.; Burysek, L.; Syrovets, T. und Simmet, T. (2003): Differential expression and regulation of protease-activated receptors in human peripheral monocytes and monocyte-derived antigen-presenting cells, Blood (Band 102), Nr. 7, Seite 2645-2652. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12805069

[47] Li, T. und He, S. (2006): Induction of IL-6 release from human T cells by PAR-1 and PAR-2 agonists, Immunol.Cell Biol. (Band 84), Nr. 5, Seite 461-466. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16869943

[48] Nystedt, S.; Emilsson, K.; Wahlestedt, C. und Sundelin, J. (1994): Molecular cloning of a potential proteinase activated receptor, Proc.Natl.Acad.Sci.U.S.A (Band 91), Nr. 20, Seite 9208-9212. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7937743

[49] Belham, C. M.; Tate, R. J.; Scott, P. H.; Pemberton, A. D.; Miller, H. R.; Wadsworth, R. M.; Gould, G. W. und Plevin, R. (1996): Trypsin stimulates proteinase-activated receptor-2-dependent and -independent activation of mitogen-activated protein kinases, Biochem.J. (Band 320 ( Pt 3)), Seite 939-946. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9003384

[50] Camerer, E.; Rottingen, J. A.; Iversen, J. G. und Prydz, H. (1996): Coagulation factors VII and X induce Ca2+ oscillations in Madin-Darby canine kidney cells only when proteolytically active, J.Biol.Chem. (Band 271), Nr. 46, Seite 29034-29042. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8910556

[51] Mirza, H.; Schmidt, V. A.; Derian, C. K.; Jesty, J. und Bahou, W. F. (1997): Mitogenic responses mediated through the proteinase-activated receptor-2 are induced by expressed forms of mast cell a, Blood (Band 90), Nr. 10, Seite 3914-3922. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9354658

[52] Molino, M.; Barnathan, E. S.; Numerof, R.; Clark, J.; Dreyer, M.; Cumashi, A.; Hoxie, J. A.; Schechter, N.; Woolkalis, M. und Brass, L. F. (1997): Interactions of mast cell tryptase with thrombin receptors and PAR-2, J.Biol.Chem. (Band 272), Nr. 7, Seite 4043-4049. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9020112

[53] Bretschneider, E.; Kaufmann, R.; Braun, M.; Wittpoth, M.; Glusa, E.; Nowak, G. und Schror, K. (1999): Evidence for proteinase-activated receptor-2 (PAR-2)-mediated mitogenesis in coronary artery smooth muscle cells, Br.J.Pharmacol. (Band 126), Nr. 8, Seite 1735-1740. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10372815

[54] Camerer, E.; Huang, W. und Coughlin, S. R. (2000): Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa, Proc.Natl.Acad.Sci.U.S.A. (Band 97), Nr. 10, Seite 5255-5260.

[55] Ishihara, H.; Connolly, A. J.; Zeng, D.; Kahn, M. L.; Zheng, Y. W.; Timmons, C.; Tram, T. und Coughlin, S. R. (1997): Protease-activated receptor 3 is a second thrombin receptor in humans, Nature (Band 386), Nr. 6624, Seite 502-506. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9087410

[56] Xu, W. F.; Andersen, H.; Whitmore, T. E.; Presnell, S. R.; Yee, D. P.; Ching, A.; Gilbert, T.; Davie, E. W. und Foster, D. C. (1998): Cloning and characterization of human protease-activated receptor 4, Proc.Natl.Acad.Sci.U.S.A (Band 95), Nr. 12, Seite 6642-6646. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9618465

[57] Kahn, M. L.; Zheng, Y. W.; Huang, W.; Bigornia, V.; Zeng, D.; Moff, S.; Farese, R. V., Jr.; Tam, C. und Coughlin, S. R. (1998): A dual thrombin receptor system for platelet activation, Nature (Band 394), Nr. 6694, Seite 690-694. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9716134

[58] Selak, M. A.; Chignard, M. und Smith, J. B. (1988): Cathepsin G is a strong platelet agonist released by neutrophils, Biochem.J. (Band 251), Nr. 1, Seite 293-299. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=3390156

[59] Sambrano, G. R.; Huang, W.; Faruqi, T.; Mahrus, S.; Craik, C. und Coughlin, S. R. (2000): Cathepsin G activates protease-activated receptor-4 in human platelets, J.Biol.Chem. (Band 275), Nr. 10, Seite 6819-6823. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10702240

[60] Blackhart, B. D.; Emilsson, K.; Nguyen, D.; Teng, W.; Martelli, A. J.; Nystedt, S.; Sundelin, J. und Scarborough, R. M. (1996): Ligand cross-reactivity within the protease-activated receptor family, J.Biol.Chem. (Band 271), Nr. 28, Seite 16466-16471. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8663335

[61] Steinberg, S. F. (2005): The cardiovascular actions of protease-activated receptors, Mol.Pharmacol. (Band 67), Nr. 1, Seite 2-11. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15371558

[62] Ludeman, M. J.; Zheng, Y. W.; Ishii, K. und Coughlin, S. R. (2004): Regulated shedding of PAR1 N-terminal exodomain from endothelial cells, J.Biol.Chem. (Band 279), Nr. 18, Seite 18592-18599. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14982936

[63] Molino, M.; Blanchard, N.; Belmonte, E.; Tarver, A. P.; Abrams, C.; Hoxie, J. A.; Cerletti, C. und Brass, L. F. (1995): Proteolysis of the human platelet and endothelial cell thrombin receptor by neutrophil-derived cathepsin G, J.Biol.Chem. (Band 270), Nr. 19, Seite 11168-11175. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7744748

[64] Jacques, S. L. und Kuliopulos, A. (2003): Protease-activated receptor-4 uses dual prolines and an anionic retention motif for thrombin recognition and cleavage, Biochem.J. (Band 376), Nr. Pt 3, Seite 733-740. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=13678420

[65] Renesto, P.; Si-Tahar, M.; Moniatte, M.; Balloy, V.; Van Dorsselaer, A.; Pidard, D. und Chignard, M. (1997): Specific inhibition of thrombin-induced cell activation by the neutrophil proteinases elastase, cathepsin G, and proteinase 3: evidence for distinct cleavage sites within the aminoterminal domain of the thrombin receptor, Blood. (Band 89), Nr. 6, Seite 1944-1953.

[66] Blackhart, B. D.; Ruslim-Litrus, L.; Lu, C. C.; Alves, V. L.; Teng, W.; Scarborough, R. M.; Reynolds, E. E. und Oksenberg, D. (2000): Extracellular mutations of protease-activated receptor-1 result in differential activation by thrombin and thrombin receptor agonist peptide, Mol.Pharmacol. (Band 58), Nr. 6, Seite 1178-1187. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11093752

[67] Vouret-Craviari, V.; Boquet, P.; Pouyssegur, J. und Obberghen-Schilling, E. (1998): Regulation of the actin cytoskeleton by thrombin in human endothelial cells: role of Rho proteins in endothelial barrier function, Mol.Biol.Cell (Band 9), Nr. 9, Seite 2639-2653. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9725917

[68] Taylor, S. J.; Chae, H. Z.; Rhee, S. G. und Exton, J. H. (1991): Activation of the beta 1 isozyme of phospholipase C by alpha subunits of the Gq class of G proteins, Nature (Band 350), Nr. 6318, Seite 516-518. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1707501

[69] Katada, T.; Bokoch, G. M.; Smigel, M. D.; Ui, M. und Gilman, A. G. (1984): The inhibitory guanine nucleotide-binding regulatory component of adenylate cyclase. Subunit dissociation and the inhibition of adenylate cyclase in S49 lymphoma cyc- and wild type membranes, J.Biol.Chem. (Band 259), Nr. 6, Seite 3586-3595. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=6142891

[70] Levitzki, A. und Bar-Sinai, A. (1991): The regulation of adenylyl cyclase by receptor-operated G proteins, Pharmacol.Ther. (Band 50), Nr. 3, Seite 271-283. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1754602

[71] Nystedt, S.; Larsson, A. K.; Aberg, H. und Sundelin, J. (1995): The mouse proteinase-activated receptor-2 cDNA and gene. Molecular cloning and functional expression, J.Biol.Chem. (Band 270), Nr. 11, Seite 5950-5955. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7890726

[72] Sabri, A.; Muske, G.; Zhang, H.; Pak, E.; Darrow, A.; Andrade-Gordon, P. und Steinberg, S. F. (2000): Signaling properties and functions of two distinct cardiomyocyte protease-activated receptors, Circ.Res. (Band 86), Nr. 10, Seite 1054-1061. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10827135

[73] Schultheiss, M.; Neumcke, B. und Richter, H. P. (1997): Endogenous trypsin receptors in Xenopus oocytes: linkage to internal calcium stores, Cell Mol.Life Sci. (Band 53), Nr. 10, Seite 842-849. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9413553

[74] Yu, R. und Hinkle, P. M. (1997): Desensitization of thyrotropin-releasing hormone receptor-mediated responses involves multiple steps, J.Biol.Chem. (Band 272), Nr. 45, Seite 28301-28307. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9353285

[75] Macfarlane, S. R.; Seatter, M. J.; Kanke, T.; Hunter, G. D. und Plevin, R. (2001): Proteinase-activated receptors, Pharmacol.Rev. (Band 53), Nr. 2, Seite 245-282. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11356985

[76] Kahn, M. L.; Nakanishi-Matsui, M.; Shapiro, M. J.; Ishihara, H. und Coughlin, S. R. (1999): Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin, J.Clin.Invest (Band 103), Nr. 6, Seite 879-887. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10079109

[77] Brass, L. F.; Manning, D. R.; Cichowski, K. und Abrams, C. S. (1997): Signaling through G proteins in platelets: to the integrins and beyond, Thromb.Haemost. (Band 78), Nr. 1, Seite 581-589. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9198220

[78] Hamberg, M.; Svensson, J. und Samuelsson, B. (1975): Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides, Proc.Natl.Acad.Sci.U.S.A (Band 72), Nr. 8, Seite 2994-2998. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1059088

[79] Stenberg, P. E.; McEver, R. P.; Shuman, M. A.; Jacques, Y. V. und Bainton, D. F. (1985): A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation, J.Cell Biol. (Band 101), Nr. 3, Seite 880-886. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2411738

[80] Hughes, P. E. und Pfaff, M. (1998): Integrin affinity modulation, Trends Cell Biol. (Band 8), Nr. 9, Seite 359-364. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9728397

[81] Sims, P. J.; Wiedmer, T.; Esmon, C. T.; Weiss, H. J. und Shattil, S. J. (1989): Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity, J.Biol.Chem. (Band 264), Nr. 29, Seite 17049-17057. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2793843

[82] Coughlin, S. R. (2001): Protease-activated receptors in vascular biology, Thromb.Haemost. (Band 86), Nr. 1, Seite 298-307. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11487018

[83] Lum, H. und Malik, A. B. (1994): Regulation of vascular endothelial barrier function, Am.J.Physiol (Band 267), Nr. 3 Pt 1, Seite L223-L241. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7943249

[84] Cirino, G.; Cicala, C.; Bucci, M. R.; Sorrentino, L.; Maraganore, J. M. und Stone, S. R. (1996): Thrombin functions as an inflammatory mediator through activation of its receptor, J.Exp.Med. (Band 183), Nr. 3, Seite 821-827. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8642286

[85] Mirza, H.; Yatsula, V. und Bahou, W. F. (1996): The proteinase activated receptor-2 (PAR-2) mediates mitogenic responses in human vascular endothelial cells, J.Clin.Invest (Band 97), Nr. 7, Seite 1705-1714. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8601636

[86] Alm, A. K.; Norstrom, E.; Sundelin, J. und Nystedt, S. (1999): Stimulation of proteinase activated receptor-2 causes endothelial cells to promote blood coagulation in vitro, Thromb.Haemost. (Band 81), Nr. 6, Seite 984-988. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10404779

[87] Jerius, H.; Beall, A.; Woodrum, D.; Epstein, A. und Brophy, C. (1998): Thrombin-induced vasospasm: cellular signaling mechanisms, Surgery (Band 123), Nr. 1, Seite 46-50. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9457222

[88] Vergnolle, N.; Hollenberg, M. D. und Wallace, J. L. (1999): Pro- and anti-inflammatory actions of thrombin: a distinct role for proteinase-activated receptor-1 (PAR1), Br.J.Pharmacol. (Band 126), Nr. 5, Seite 1262-1268. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10205017

[89] Vergnolle, N.; Hollenberg, M. D.; Sharkey, K. A. und Wallace, J. L. (1999): Characterization of the inflammatory response to proteinase-activated receptor-2 (PAR2)-activating peptides in the rat paw, Br.J.Pharmacol. (Band 127), Nr. 5, Seite 1083-1090. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10455252

[90] Naldini, A. und Carney, D. H. (1996): Thrombin modulation of natural killer activity in human peripheral lymphocytes, Cell Immunol. (Band 172), Nr. 1, Seite 35-42.

[91] Naldini, A.; Sower, L.; Bocci, V.; Meyers, B. und Carney, D. H. (1998): Thrombin receptor expression and responsiveness of human monocytic cells to thrombin is linked to interferon-induced cellular differentiation, J.Cell Physiol. (Band 177), Nr. 1, Seite 76-84.

[92] Schaffner, A.; Rhyn, P.; Schoedon, G. und Schaer, D. J. (2005): Regulated expression of platelet factor 4 in human monocytes--role of PARs as a quantitatively important monocyte activation pathway, J.Leukoc.Biol. (Band 78), Nr. 1, Seite 202-209.

[93] Corvera, C. U.; Dery, O.; McConalogue, K.; Gamp, P.; Thoma, M.; Al Ani, B.; Caughey, G. H.; Hollenberg, M. D. und Bunnett, N. W. (1999): Thrombin and mast cell tryptase regulate guinea-pig myenteric neurons through proteinase-activated receptors-1 and -2, J.Physiol (Band 517 ( Pt 3)), Seite 741-756. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10358115

[94] Steinhoff, M.; Vergnolle, N.; Young, S. H.; Tognetto, M.; Amadesi, S.; Ennes, H. S.; Trevisani, M.; Hollenberg, M. D.; Wallace, J. L.; Caughey, G. H.; Mitchell, S. E.; Williams, L. M.; Geppetti, P.; Mayer, E. A. und Bunnett, N. W. (2000): Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism, Nat.Med. (Band 6), Nr. 2, Seite 151-158. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10655102

[95] Yanagisawa, M.; Kurihara, H.; Kimura, S.; Tomobe, Y.; Kobayashi, M.; Mitsui, Y.; Yazaki, Y.; Goto, K. und Masaki, T. (1988): A novel potent vasoconstrictor peptide produced by vascular endothelial cells, Nature (Band 332), Nr. 6163, Seite 411-415. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2451132

[96] Inoue, A.; Yanagisawa, M.; Kimura, S.; Kasuya, Y.; Miyauchi, T.; Goto, K. und Masaki, T. (1989): The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes, Proc.Natl.Acad.Sci.U.S.A (Band 86), Nr. 8, Seite 2863-2867. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2649896

[97] Schmidt, M.; Kroger, B.; Jacob, E.; Seulberger, H.; Subkowski, T.; Otter, R.; Meyer, T.; Schmalzing, G. und Hillen, H. (1994): Molecular characterization of human and bovine endothelin converting enzyme (ECE-1), FEBS Lett. (Band 356), Nr. 2-3, Seite 238-243. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7805846

[98] Douglas, S. A. und Ohlstein, E. H. (1997): Signal transduction mechanisms mediating the vascular actions of endothelin, J.Vasc.Res. (Band 34), Nr. 3, Seite 152-164. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9226297

[99] Arai, H.; Hori, S.; Aramori, I.; Ohkubo, H. und Nakanishi, S. (1990): Cloning and expression of a cDNA encoding an endothelin receptor, Nature (Band 348), Nr. 6303, Seite 730-732. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2175396

[100] Sakurai, T.; Yanagisawa, M.; Takuwa, Y.; Miyazaki, H.; Kimura, S.; Goto, K. und Masaki, T. (1990): Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor, Nature (Band 348), Nr. 6303, Seite 732-735. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2175397

[101] Masaki, T.; Miwa, S.; Sawamura, T.; Ninomiya, H. und Okamoto, Y. (1999): Subcellular mechanisms of endothelin action in vascular system, Eur.J.Pharmacol. (Band 375), Nr. 1-3, Seite 133-138. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10443571

[102] Rubanyi, G. M. und Polokoff, M. A. (1994): Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology, Pharmacol.Rev. (Band 46), Nr. 3, Seite 325-415. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7831383

[103] Sakamoto, A.; Yanagisawa, M.; Sawamura, T.; Enoki, T.; Ohtani, T.; Sakurai, T.; Nakao, K.; Toyo-oka, T. und Masaki, T. (1993): Distinct subdomains of human endothelin receptors determine their selectivity to endothelinA-selective antagonist and endothelinB-selective agonists, J.Biol.Chem. (Band 268), Nr. 12, Seite 8547-8553. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8473300

[104] Orry, A. J. und Wallace, B. A. (2000): Modeling and docking the endothelin G-protein-coupled receptor, Biophys.J. (Band 79), Nr. 6, Seite 3083-3094. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11106614

[105] Takigawa, M.; Sakurai, T.; Kasuya, Y.; Abe, Y.; Masaki, T. und Goto, K. (1995): Molecular identification of guanine-nucleotide-binding regulatory proteins which couple to endothelin receptors, Eur.J.Biochem. (Band 228), Nr. 1, Seite 102-108. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7882989

[106] Sugden, P. H. und Clerk, A. (2005): Endothelin signalling in the cardiac myocyte and its pathophysiological relevance, Curr.Vasc.Pharmacol. (Band 3), Nr. 4, Seite 343-351. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16248777

[107] Arai, K.; Maruyama, Y.; Nishida, M.; Tanabe, S.; Takagahara, S.; Kozasa, T.; Mori, Y.; Nagao, T. und Kurose, H. (2003): Differential requirement of G alpha12, G alpha13, G alphaq, and G beta gamma for endothelin-1-induced c-Jun NH2-terminal kinase and extracellular signal-regulated kinase activation, Mol.Pharmacol. (Band 63), Nr. 3, Seite 478-488. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12606754

[108] Trevisi, L.; Bova, S.; Cargnelli, G.; Ceolotto, G. und Luciani, S. (2002): Endothelin-1-induced arachidonic acid release by cytosolic phospholipase A2 activation in rat vascular smooth muscle via extracellular signal-regulated kinases pathway, Biochem.Pharmacol. (Band 64), Nr. 3, Seite 425-431. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12147293

[109] Wu-Wong, J. R.; Dayton, B. D. und Opgenorth, T. J. (1996): Endothelin-1-evoked arachidonic acid release: a Ca(2+)-dependent pathway, Am.J.Physiol (Band 271), Nr. 3 Pt 1, Seite C869-C877. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8843717

[110] Curtis, T. M. und Scholfield, C. N. (2000): Transient Ca2+-activated Cl-currents with endothelin in isolated arteriolar smooth muscle cells of the choroid, Invest Ophthalmol.Vis.Sci. (Band 41), Nr. 8, Seite 2279-2285. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10892874

[111] Masaki, T. (1995): Possible role of endothelin in endothelial regulation of vascular tone, Annu.Rev.Pharmacol.Toxicol. (Band 35), Seite 235-255. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7598493

[112] Iwamuro, Y.; Miwa, S.; Zhang, X. F.; Minowa, T.; Enoki, T.; Okamoto, Y.; Hasegawa, H.; Furutani, H.; Okazawa, M.; Ishikawa, M.; Hashimoto, N. und Masaki, T. (1999): Activation of three types of voltage-independent Ca2+ channel in A7r5 cells by endothelin-1 as revealed by a novel Ca2+ channel blocker LOE 908, Br.J.Pharmacol. (Band 126), Nr. 5, Seite 1107-1114. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10204997

[113] Zhang, X. F.; Iwamuro, Y.; Enoki, T.; Okazawa, M.; Lee, K.; Komuro, T.; Minowa, T.; Okamoto, Y.; Hasegawa, H.; Furutani, H.; Miwa, S. und Masaki, T. (1999): Pharmacological characterization of Ca2+ entry channels in endothelin-1-induced contraction of rat aorta using LOE 908 and SK&F 96365, Br.J.Pharmacol. (Band 127), Nr. 6, Seite 1388-1398. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10455288

[114] Minowa, T.; Miwa, S.; Kobayashi, S.; Enoki, T.; Zhang, X. F.; Komuro, T.; Iwamuro, Y. und Masaki, T. (1997): Inhibitory effect of nitrovasodilators and cyclic GMP on ET-1-activated Ca(2+)-permeable nonselective cation channel in rat aortic smooth muscle cells, Br.J.Pharmacol. (Band 120), Nr. 8, Seite 1536-1544. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9113376

[115] Jagroop, I. A.; Daskalopoulou, S. S. und Mikhailidis, D. P. (2005): Endothelin-1 and human platelets, Curr.Vasc.Pharmacol. (Band 3), Nr. 4, Seite 393-399.

[116] Malendowicz, L. K.; Brelinska, R.; De Caro, R.; Trejer, M. und Nussdorfer, G. G. (1998): Endothelin-1, acting via the A receptor subtype, stimulates thymocyte proliferation in the rat, Life Sci. (Band 62), Nr. 21, Seite 1959-1963.

[117] Sampaio, A. L.; Rae, G. A. und Henriques, M. M. (2000): Role of endothelins on lymphocyte accumulation in allergic pleurisy, J.Leukoc.Biol. (Band 67), Nr. 2, Seite 189-195.

[118] Guruli, G.; Pflug, B. R.; Pecher, S.; Makarenkova, V.; Shurin, M. R. und Nelson, J. B. (2004): Function and survival of dendritic cells depend on endothelin-1 and endothelin receptor autocrine loops, Blood. (Band 104), Nr. 7, Seite 2107-2115.

[119] Miyauchi, T. und Masaki, T. (1999): Pathophysiology of endothelin in the cardiovascular system, Annu.Rev.Physiol (Band 61), Seite 391-415. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10099694

[120] Sakai, S.; Miyauchi, T.; Kobayashi, M.; Yamaguchi, I.; Goto, K. und Sugishita, Y. (1996): Inhibition of myocardial endothelin pathway improves long-term survival in heart failure, Nature (Band 384), Nr. 6607, Seite 353-355. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8934519

[121] Bousette, N. und Giaid, A. (2003): Endothelin-1 in atherosclerosis and other vasculopathies, Can.J.Physiol Pharmacol. (Band 81), Nr. 6, Seite 578-587. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12839269

[122] Seiler, S. M.; Peluso, M.; Tuttle, J. G.; Pryor, K.; Klimas, C.; Matsueda, G. R. und Bernatowicz, M. S. (1996): Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonists, Mol.Pharmacol. (Band 49), Nr. 1, Seite 190-197.

[123] Rasmussen, U. B.; Gachet, C.; Schlesinger, Y.; Hanau, D.; Ohlmann, P.; Obberghen-Schilling, E.; Pouyssegur, J.; Cazenave, J. P. und Pavirani, A. (1993): A peptide ligand of the human thrombin receptor antagonizes alpha-thrombin and partially activates platelets, J.Biol.Chem. (Band 268), Nr. 19, Seite 14322-14328.

[124] Lehmberg, J.; Putz, C.; Furst, M.; Beck, J.; Baethmann, A. und Uhl, E. (2003): Impact of the endothelin-A receptor antagonist BQ 610 on microcirculation in global cerebral ischemia and reperfusion, Brain Res. (Band 961), Nr. 2, Seite 277-286.

[125] Wallukat, G.; Morwinski, R; Nissen, E.; Müller, J. und Luft, F. C. (2003): Effects of the tryptase receptor activating peptide and antibodies against the tryptase receptor PAR-2 on neonatal rat cardiomyocytes in culture, Matsumori, A, Cardiomyopathies and heart failure: Biomolecular, infectious and immune mechanisms , Seite 173-184, Kluwer Academic Publishers, Boston, ISBN: 1-4020-7438-7.

[126] Albrecht, S.; Luther, T.; Grossmann, H.; Flössel, C.; Kotzsch, M. und Müller, M. (1992): An ELISA for tissue factor using monoclonal antibodies, Blood Coagul.Fibrinolysis. (Band 3), Nr. 3, Seite 263-270.

[127] Wollenberger, A. (1985): Isolated heart cells as a model of the myocardium, Basic Res.Cardiol. (Band 80 Suppl 2:9-13.), Seite 9-13.

[128] Kolde, H.-J. (2001): Haemostasis, Pentapharm Ltd., Basel.

[129] Auron, P. E. (1998): The interleukin 1 receptor: ligand interactions and signal transduction, Cytokine Growth Factor Rev. (Band 9), Nr. 3-4, Seite 221-237.

[130] Kereveur, A.; Enjyoji, K.; Masuda, K.; Yutani, C. und Kato, H. (2001): Production of tissue factor pathway inhibitor in cardiomyocytes and its upregulation by interleukin-1, Thromb.Haemost. (Band 86), Nr. 5, Seite 1314-1319.

[131] Shindo, T.; Ikeda, U.; Ohkawa, F.; Kawahara, Y.; Yokoyama, M. und Shimada, K. (1995): Nitric oxide synthesis in cardiac myocytes and fibroblasts by inflammatory cytokines, Cardiovasc.Res. (Band 29), Nr. 6, Seite 813-819.

[132] Banchereau, J. und Galizzi, J. P. (1990): Receptors for interleukin 4, interleukin 5 and interleukin 6, Ann.Ist.Super.Sanita. (Band 26), Nr. 3-4, Seite 453-467.

[133] Saito, M.; Yoshida, K.; Hibi, M.; Taga, T. und Kishimoto, T. (1992): Molecular cloning of a murine IL-6 receptor-associated signal transducer, gp130, and its regulated expression in vivo, J.Immunol. (Band 148), Nr. 12, Seite 4066-4071.

[134] Villegas, S.; Villarreal, F. J. und Dillmann, W. H. (2000): Leukemia Inhibitory Factor and Interleukin-6 downregulate sarcoplasmic reticulum Ca2+ ATPase (SERCA2) in cardiac myocytes, Basic Res.Cardiol. (Band 95), Nr. 1, Seite 47-54.

[135] Tanaka, T.; Kanda, T.; Takahashi, T.; Saegusa, S.; Moriya, J. und Kurabayashi, M. (2004): Interleukin-6-induced reciprocal expression of SERCA and natriuretic peptides mRNA in cultured rat ventricular myocytes, J.Int.Med.Res. (Band 32), Nr. 1, Seite 57-61.

[136] Smart, N.; Mojet, M. H.; Latchman, D. S.; Marber, M. S.; Duchen, M. R. und Heads, R. J. (2006): IL-6 induces PI 3-kinase and nitric oxide-dependent protection and preserves mitochondrial function in cardiomyocytes, Cardiovasc.Res. (Band 69), Nr. 1, Seite 164-177.

[137] Palsson-McDermott, E. M. und O'Neill, L. A. (2004): Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4, Immunology. (Band 113), Nr. 2, Seite 153-162.

[138] Tavener, S. A. und Kubes, P. (2005): Is there a role for cardiomyocyte toll-like receptor 4 in endotoxemia?, Trends Cardiovasc.Med. (Band 15), Nr. 5, Seite 153-157.

[139] Calabro, P.; Willerson, J. T. und Yeh, E. T. (2003): Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells, Circulation. (Band 108), Nr. 16, Seite 1930-1932.

[140] Klouche, M.; Bhakdi, S.; Hemmes, M. und Rose-John, S. (1999): Novel path to activation of vascular smooth muscle cells: up-regulation of gp130 creates an autocrine activation loop by IL-6 and its soluble receptor, J.Immunol. (Band 163), Nr. 8, Seite 4583-4589.

[141] Kaur, J.; Dhaunsi, G. S. und Turner, R. B. (2004): Interleukin-1 and nitric oxide increase NADPH oxidase activity in human coronary artery smooth muscle cells, Med.Princ.Pract. (Band 13), Nr. 1, Seite 26-29.

[142] Beaumont, D. O.; Whitten, K. W.; Mock, R. G. und Slattery, C. W. (1989): Measuring platelet function with platelet shape change, an early event in aggregation, Thromb.Res. (Band 53), Nr. 2, Seite 109-127.

[143] Frishman, W. H.; Huberfeld, S.; Okin, S.; Wang, Y. H.; Kumar, A. und Shareef, B. (1995): Serotonin and serotonin antagonism in cardiovascular and non-cardiovascular disease, J.Clin.Pharmacol. (Band 35), Nr. 6, Seite 541-572.

[144] Dorsam, R. T.; Kim, S.; Jin, J. und Kunapuli, S. P. (2002): Coordinated signaling through both G12/13 and G(i) pathways is sufficient to activate GPIIb/IIIa in human platelets, J.Biol.Chem. (Band 277), Nr. 49, Seite 47588-47595.

[145] Barradas, M. A. und Mikhailidis, D. P. (1992): Serotonin, histamine and platelets in vascular disease with special reference to peripheral vascular disease, Braz.J.Med.Biol.Res. (Band 25), Nr. 11, Seite 1063-1076.

[146] Luscher, T. F. (1993): Platelet-vessel wall interaction: role of nitric oxide, prostaglandins and endothelins, Baillieres Clin.Haematol. (Band 6), Nr. 3, Seite 609-627.

[147] Tarpey, M. M.; White, C. R.; Suarez, E.; Richardson, G.; Radi, R. und Freeman, B. A. (1999): Chemiluminescent detection of oxidants in vascular tissue. Lucigenin but not coelenterazine enhances superoxide formation, Circ.Res. (Band 84), Nr. 10, Seite 1203-1211.

[148] Janiszewski, M.; Souza, H. P.; Liu, X.; Pedro, M. A.; Zweier, J. L. und Laurindo, F. R. (2002): Overestimation of NADH-driven vascular oxidase activity due to lucigenin artifacts, Free Radic.Biol.Med. (Band 32), Nr. 5, Seite 446-453.

[149] Liochev, S. I. und Fridovich, I. (1998): Lucigenin as mediator of superoxide production: revisited, Free Radic.Biol.Med. (Band 25), Nr. 8, Seite 926-928.

[150] Skatchkov, M. P.; Sperling, D.; Hink, U.; Mulsch, A.; Harrison, D. G.; Sindermann, I.; Meinertz, T. und Munzel, T. (1999): Validation of lucigenin as a chemiluminescent probe to monitor vascular superoxide as well as basal vascular nitric oxide production, Biochem.Biophys.Res.Commun. (Band %19;254), Nr. 2, Seite 319-324.

[151] Dörffel, Y.; Lätsch, C.; Stuhlmüller, B.; Schreiber, S.; Scholze, S.; Burmester, G. R. und Scholze, J. (1999): Preactivated peripheral blood monocytes in patients with essential hypertension, Hypertension. (Band 34), Nr. 1, Seite 113-117.

[152] Dörffel, Y.; Franz, S.; Pruss, A.; Neumann, G.; Rohde, W.; Burmester, G. R. und Scholze, J. (2001): Preactivated monocytes from hypertensive patients as a factor for atherosclerosis?, Atherosclerosis. (Band 157), Nr. 1, Seite 151-160.

[153] King, J. M.; Srivastava, K. D.; Stefano, G. B.; Bilfinger, T. V.; Bahou, W. F. und Magazine, H. I. (1997): Human monocyte adhesion is modulated by endothelin B receptor-coupled nitric oxide release, J.Immunol. (Band 158), Nr. 2, Seite 880-886.

[154] Browatzki, M.; Pfeiffer, C. A.; Schmidt, J. und Kranzhofer, R. (2005): Endothelin-1 induces CD40 but not IL-6 in human monocytes via the proinflammatory transcription factor NF-kappaB, Eur.J.Med.Res. (Band %20;10), Nr. 5, Seite 197-201.


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
16.01.2009